Tracking Flunitrazepam in Blood with LC-MS

Flunitrazepam is a powerful sleeping medication that has been found in many cases of fatal overdose and suicide. However, by the time an autopsy is performed, the drug is often either undetectable in the blood or present at much lower levels than would be expected, making it difficult for investigators to piece together what happened. Researchers at Chiba University (Japan) conducted a study looking at how flunitrazepam behaves in human blood over time, using liquid chromatography coupled with quadrupole-orbital trap mass spectrometry (LC-Q-O-MS) to track the drug and better understand why it seems to disappear. A paper based on this research was published in Forensic Toxicology.¹

What is the Challenge Flunitrazepam Presents Forensic Investigators?

Flunitrazepam is a prescription sleeping medication typically given to people with severe, long-term insomnia or to patients preparing for surgery. Like other sleep aids, it is intended only for short-term use. In Japan, it is one of the leading causes of fatal poisoning.² When taken in lethal amounts, the drug reaches a specific concentration range in the blood, and, in forensic investigations, measuring that concentration accurately is essential to confirming that someone died from a flunitrazepam overdose. The problem is that by the time an autopsy is performed, the drug is often undetectable in the blood or present at much lower levels than would be expected. It is not yet fully understood why this happens. Forensic investigators have previously relied on a breakdown product of the drug as an indirect marker of its presence, but that compound also changes in the blood over time, making it unreliable on its own. As a result, there is a pressing need for a more dependable indicator that investigators can use to confirm flunitrazepam poisoning with confidence.^3-5

How Does Flunitrazepam Break Down in the Blood After Death, and What Does That Mean for Forensic Investigations?

The researchers tracked how flunitrazepam and its breakdown products behaved in human blood, both in laboratory experiments and in blood samples taken from people who had died after intentionally taking the drug. What they found was a kind of chemical chain reaction: once in the blood, flunitrazepam is converted into a different compound by a naturally occurring enzyme, and that compound is then further broken down by hemoglobin. This process produces a specific end product that was found both in lab samples and in the blood of some of the deceased individuals studied. The researchers concluded that this end product forms as the drug degrades over time, a process driven by the natural changes that occur in the body after death. Crucially, because this breakdown follows a predictable pattern, the end product could potentially serve as a chemical "fingerprint," one that forensic investigators could use to work backward and estimate how much flunitrazepam was actually present in a person's blood at the time of death, even when little or none of the original drug remains detectable.¹

“The post-mortem degradation product,” report the authors of the paper,¹ “may be a valuable biomarker for correcting blood flunitrazepam concentration at the time of death in clinical cases.”

Read More on Similar Topics
Metabolomics and Machine Learning for PMI Estimation: UHPLC–QTOF-MS Profiling of Postmortem Biomarkers

References

1. Yamagishi, Y.; Inoue, H.; Nagasawa, S. et al. Post-Mortem Degradation of Flunitrazepam by Aldehyde Oxidase 1 and Hemoglobin in Blood. Forensic Toxicol. 2026. DOI: 10.1007/s11419-026-00777-0
2. Kudo, K.; Ishida, T.; Hikiji, W. et al. Pattern of Poisoning in Japan: Selection of Drugs and Poisons for Systematic Toxicological Analysis. Forensic Toxicol. 2010, 28, 25–32. DOI: 10.1007/s11419-009-0088-8
3. Schulz, M.; Schmoldt, A.; Andresen-Streichert, H. et al. Revisited: Therapeutic and Toxic Blood Concentrations of More than 1100 Drugs and Other Xenobiotics. Crit Care 2020, 24 (1), 195. DOI: 10.1186/s13054-020-02915-5
4. Drummer, O. H.; Syrjanen, M. L.; Cordner, S. M. Deaths Involving the Benzodiazepine Flunitrazepam. Am J Forensic Med Pathol. 1993, 14 (3), 238-243. DOI: 10.1097/00000433-199309000-00012
5. Mata, D. C. Stability of 26 Sedative Hypnotics in Six Toxicological Matrices at Different Storage Conditions. J Anal Toxicol. 2016, 40 (8), 663-668. DOI: 10.1093/jat/bkw084